VAXIL BIO LTD (VXL.CA) Stock Cash Flow
Canada - TSX Venture Exchange - TSX-V:VXL - CA92243L2066 - Common Stock
0.145 CAD
+0 (+3.57%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -68.00K | -178.00K | -254.00K | -584.00K | -986.00K | |||
| Depreciation Amortization | N/A | N/A | N/A | 2.00K | 25.00K | |||
| Change In Working Capital | -44.00K | -49.00K | -327.00K | -169.00K | -193.00K | |||
| Other non cash items | -101.00K | -13.00K | 20.00K | 17.00K | 70.00K | |||
| OPERATING CASH FLOW | -213.00K | -240.00K | -561.00K | -734.00K | -1.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | N/A | -250.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -250.00K | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -9.00K | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | 0.00 | 1.82M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | N/A | N/A | 0.00 | 1.81M | |||
| Exchange Rate Effect | -2.00K | 0.00 | -11.00K | 3.00K | 7.00K | |||
| CHANGE IN CASH | -88.00K | -490.00K | -572.00K | -731.00K | 731.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -213.00K | -240.00K | -561.00K | -734.00K | -1.08M | |||
| FREE CASH FLOW | -213.00K | -240.00K | -561.00K | -734.00K | -1.08M | |||
All data in CAD